BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 8669043)

  • 41. Nipple-sparing mastectomy in association with intra operative radiotherapy (ELIOT): A new type of mastectomy for breast cancer treatment.
    Petit JY; Veronesi U; Orecchia R; Luini A; Rey P; Intra M; Didier F; Martella S; Rietjens M; Garusi C; DeLorenzi F; Gatti G; Leon ME; Casadio C
    Breast Cancer Res Treat; 2006 Mar; 96(1):47-51. PubMed ID: 16261402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ductal carcinoma-in-situ.
    Wickerham DL
    J Clin Oncol; 2001 Sep; 19(18 Suppl):98S-100S. PubMed ID: 11560982
    [No Abstract]   [Full Text] [Related]  

  • 43. [Principles and limits of breast-saving therapy of small breast cancers].
    Thomsen K; Stegner HE; Frischbier HJ
    Gynakologe; 1980 Jun; 13(2):56-66. PubMed ID: 6299909
    [No Abstract]   [Full Text] [Related]  

  • 44. Radiation therapy for ductal carcinoma in situ: is it really worth it?
    Thorat MA; Parmar V; Nadkarni MS; Badwe RA
    J Clin Oncol; 2007 Feb; 25(4):461-2; author reply 462. PubMed ID: 17264349
    [No Abstract]   [Full Text] [Related]  

  • 45. [Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17].
    Noël G; Proudhom MA; Mazeron JJ
    Cancer Radiother; 1999; 3(4):342-3. PubMed ID: 10486547
    [No Abstract]   [Full Text] [Related]  

  • 46. 17 beta-Hydroxysteroid dehydrogenase type 1 and type 2 in ductal carcinoma in situ and intraductal proliferative lesions of the human breast.
    Ariga N; Moriya T; Suzuki T; Kimura M; Ohuchi N; Satomi S; Sasano H
    Anticancer Res; 2000; 20(2B):1101-8. PubMed ID: 10810403
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Ductal carcinoma in situ: role of the boost].
    Azria D; Auvray H; Barillot I; Baumann P; Benyoucef A; Bons-Rosset F; Bontemps P; Bourgier C; Breton-Callu C; Cowen D; Cretin J; Delalande B; Denis F; Ellis S; Gaci Z; Hannoun-Lévy JM; Hasbini A; Hennequin C; Lagrange JL; Lartigau E; Latorzeff I; Le Blanc-Onfroy M; Lecouillard I; Lemanski C; Levy C; Maingon P; Marchal C; Monnier A; Pradier O; Racadot S; Romestaing P; Serin D; Simon JM; Teyssier E; Tallet A; Tolédano A; Belkacémi Y
    Cancer Radiother; 2008 Nov; 12(6-7):571-6. PubMed ID: 18703372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The dilemma of lobular carcinoma in situ at percutaneous biopsy: to excise or to monitor.
    Gabriel H
    AJR Am J Roentgenol; 1999 Aug; 173(2):300-2. PubMed ID: 10430123
    [No Abstract]   [Full Text] [Related]  

  • 49. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Should all patients undergoing breast conserving therapy for DCIS receive radiation therapy? No. One size does not fit all: an argument against the routine use of radiation therapy for all patients with ductal carcinoma in situ of the breast who elect breast conservation.
    Silverstein MJ; Lagios MD
    J Surg Oncol; 2007 Jun; 95(8):605-9. PubMed ID: 17192948
    [No Abstract]   [Full Text] [Related]  

  • 51. In situ carcinomas of the female breast. Diagnostic and therapeutic aspects with special reference to histological growth patterns. Clinical review.
    Blichert-Toft M; Andersen J; Dyreborg U
    Acta Chir Scand; 1990 Feb; 156(2):113-9. PubMed ID: 2158737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Physician recommendations regarding tamoxifen and patient utilization of tamoxifen after surgery for ductal carcinoma in situ.
    Yen TW; Hunt KK; Mirza NQ; Thomas ES; Singletary SE; Babiera GV; Meric-Bernstam F; Buchholz TA; Feig BW; Ross MI; Ames FC; Theriault RL; Kuerer HM
    Cancer; 2004 Mar; 100(5):942-9. PubMed ID: 14983489
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
    Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
    Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Whole-breast irradiation following breast-conserving surgery of ductal carcinomain situ is indispensable. Update of the 2005 DEGRO (German Society of Radiation Oncology) Guideline on Radiation Therapy for Breast Cancer].
    Souchon R; Budach W; Dunst J; Feyer P; Haase W; Harms W; Sautter Bihl ML; Wenz F; Sauer R;
    Strahlenther Onkol; 2006 Aug; 182(8):429-30. PubMed ID: 16896587
    [No Abstract]   [Full Text] [Related]  

  • 55. Management of ductal carcinoma in situ of the breast. Provincial Breast Cancer Disease Site Group.
    Wright JR; Whelan TJ; McCready DR; O'Malley FP
    Cancer Prev Control; 1998 Dec; 2(6):312-9. PubMed ID: 10470463
    [No Abstract]   [Full Text] [Related]  

  • 56. [Value of radiotherapy in breast cancer. Breast preservation rises to 80%].
    Seegenschmiedt MH; Strittmatter HJ
    MMW Fortschr Med; 2003 Jun; 145(25):26-30. PubMed ID: 12891848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Breast conservation surgery and interstitial brachytherapy in the management of locally recurrent carcinoma of the breast: the Allegheny General Hospital experience.
    Trombetta M; Julian T; Bhandari T; Werts ED; Miften M; Parda D
    Brachytherapy; 2008; 7(1):29-36. PubMed ID: 18201940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of breast biopsy specimens in patients considered for treatment by conservative surgery and radiation therapy for early breast cancer.
    Connolly JL; Schnitt SJ
    Pathol Annu; 1988; 23 Pt 1():1-23. PubMed ID: 2838791
    [No Abstract]   [Full Text] [Related]  

  • 59. Current management of primary breast cancer. Part II: Adjuvant therapy and management of stage III disease and in-situ carcinoma.
    Lopez MJ; Andriole DP
    Mo Med; 1990 Oct; 87(10):757-62. PubMed ID: 2175383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bilateral primary breast carcinoma in a man.
    van Tets WF; Leenen LP; Roukema JA; Pijpers PM
    Neth J Surg; 1990 Dec; 42(6):158-60. PubMed ID: 2178234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.